Vaccines Archives | Report Store | Pharma intelligence

Disease Analysis: Human Papillomavirus (HPV) Vaccines

Worldwide vaccination programs for human papillomavirus (HPV) have evolved substantially over the last decade.

May 13, 2020

Find out more

Pneumococcal Vaccines Market and Forecast Analysis to 2024

Streptococcus pneumoniae is a major cause of morbidity and mortality worldwide, with an estimated 1.6 million people dying of invasive pneumococcal disease (IPD) each year. IPD primarily comprises septicemia, pneumonia, and meningitis.

April 1, 2020

Find out more

Meningococcal Vaccines Disease Coverage Forecast and Market Analysis to 2027

Meningitis is an infection of the meninges, the membranes surrounding the brain and spinal cord. It can be caused by a number of different viral and bacterial pathogens including Haemophilus influenzae b (Hib) and Streptococcus pneumoniae.

September 3, 2019

Find out more

Seasonal Influenza Vaccines

Seasonal influenza is an acute viral infection that is spread by person-to-person transmission. Influenza, commonly referred to as the flu, circulates worldwide and can affect anyone in any age group, although annual epidemics peak during winter in temperate climates.

January 10, 2019

Find out more

Respiratory Syncytial Virus Vaccines

Respiratory syncytial virus (RSV) is an enveloped, non-segmented, single-stranded, negative-sense RNA virus belonging to the Paramyxoviridae family.

October 5, 2018

Find out more

Dengue Vaccines

Dengue fever is an emerging flaviviral infection transmitted mainly by Aedes aegypti and Aedes albopictus mosquitoes.

January 4, 2018

Find out more

Datamonitor Healthcare Seasonal Influenza Vaccines KOL Interviews

$599.00

Datamonitor Healthcare interviewed two infectious disease experts, one based in the US and one in France, to gauge their views on the seasonal influenza vaccines market, its outlook over the next five years and any key events that are likely to take place, including the impact of novel quadrivalent inactivated influenza vaccines and other incremental advances

April 18, 2017

Find out more